A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

729

HTML

6670

Figures (1-5)

171

Tables (1-3)

111

Sum=7681

Jan 14, 2010 (publication date) through Apr 15, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Jan 14, 2010; 16(2): 167-175
Published online Jan 14, 2010. doi: 10.3748/wjg.v16.i2.167

Table 3 Percent of patients with variation of enterococci and enterobacteriaceae colonization of feces (day 0 vs day -4) n (%)

	*Patients colonized with La1* (n = 9)**	*Patients not colonized with La1* (n = 22)**
Enterobacteriaceae
Unchanged/increased	2 (22.2)	9 (40.9)
Decreased	7 (77.8)	13 (59.1)
Enterococci
Unchanged/increased	1 (11.1)	11 (50)
Decreased	8 (88.9)^a	11 (50)

^aP = 0.004 vs unchanged/increased.

Citation: Gianotti L, Morelli L, Galbiati F, Rocchetti S, Coppola S, Beneduce A, Gilardini C, Zonenschain D, Nespoli A, Braga M. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World J Gastroenterol 2010; 16(2): 167-175
URL: https://www.wjgnet.com/1007-9327/full/v16/i2/167.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i2.167